GlaxoSmithkline Pharmaceuticals Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2018. For the quarter, the company reported revenue from operations of INR 7,356.5 million compared to INR 6,070.9 million a year ago. Profit before exceptional items and tax was INR 1,465.9 million compared to INR 258.2 million a year ago. Profit before tax was INR 1,383.1 million compared to INR 384.6 million a year ago. Profit was INR 885.9 million or INR 10.46 per basic and diluted share compared to INR 264.2 million or INR 3.12 per basic and diluted share a year ago.